Capivasertib – a huge success story for UK science 08 Dec 2022 The latest major breakthrough in cancer is a drug called capivasertib, which has shown ‘remarkable’ results against advanced breast cancer in its first phase III trial. Henry French gives an update Find out more Show/Hide
A visionary research leader, ally and mentor - Professor Paul Workman steps down as CEO 27 Aug 2021 As Professor Paul Workman steps down as Chief Executive of The Institute of Cancer Research, London, colleagues from the ICR and beyond share memories of and reflections on his impact in cancer research. Find out more Show/Hide